Different  	Different  	 JJ	B-NP
sensitivity  	sensitivity  	 NN	I-NP
levels  	levels  	 NNS	I-NP
to  	to  	 TO	O
norspermidine  	norspermidine  	 VB	O
on  	on  	 IN	O
biofilm  	biofilm  	 JJ	B-NP
formation  	formation  	 NN	I-NP
in  	in  	 IN	O
clinical  	clinical  	 JJ	O
and  	and  	 CC	O
commensal  	commensal  	 FW	B-NP
Staphylococcus  	Staphylococcus  	 FW	I-NP
epidermidis  	epidermidis  	 FW	I-NP
strains  	strains  	 FW	I-NP
Biofilm  	Biofilm  	 FW	I-NP
formation  	formation  	 NN	I-NP
on  	on  	 IN	O
medical  	medical  	 JJ	O
and  	and  	 CC	O
surgical  	surgical  	 JJ	B-NP
devices  	devices  	 NNS	I-NP
is  	is  	 VBZ	O
the  	the  	 DT	O
main  	main  	 JJ	O
virulence  	virulence  	 NN	B-NP
factor  	factor  	 NN	I-NP
of  	of  	 IN	I-NP
Staphylococcus  	Staphylococcus  	 NNP	I-NP
epidermidis 	epidermidis 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
recent  	recent  	 JJ	O
study  	study  	 NN	O
has  	has  	 VBZ	O
shown  	shown  	 VBN	O
that  	that  	 IN	O
norspermidine  	norspermidine  	 JJ	O
inhibits  	inhibits  	 NN	O
and  	and  	 CC	O
disassembles  	disassembles  	 VBG	O
the  	the  	 DT	O
biofilm  	biofilm  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
wild-type  	wild-type  	 JJ	B-NP
Bacillus  	Bacillus  	 NN	I-NP
subtilis  	subtilis  	 VBD	O
NCBI3610  	NCBI3610  	 CD	O
strain 	strain 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
study 	study 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
effect  	effect  	 NN	O
of  	of  	 IN	O
norspermidine  	norspermidine  	 NN	B-NP
on  	on  	 IN	O
S. epidermidis  	S. epidermidis  	 CD	B-NP
biofilm  	biofilm  	 JJ	I-NP
formation  	formation  	 NN	I-NP
of  	of  	 IN	O
clinical  	clinical  	 JJ	O
or  	or  	 CC	O
commensal  	commensal  	 JJ	B-NP
strains  	strains  	 NNS	I-NP
was  	was  	 VBD	O
tested 	tested 	 VBN	O
.  	.  	 .	O
Biofilm  	Biofilm  	 RB	O
producing  	producing  	 VBG	B-NP
strains  	strains  	 NNS	I-NP
of  	of  	 IN	I-NP
S. epidermidis  	S. epidermidis  	 NNP	I-NP
were  	were  	 VBD	O
isolated  	isolated  	 VBN	O
from  	from  	 IN	O
healthy  	healthy  	 JJ	B-NP
skin  	skin  	 NN	I-NP
( 	( 	 -LRB-	O
HS 	HS 	 NNP	B-NP
;  	;  	 :	O
n = 3 	n = 3 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
healthy  	healthy  	 JJ	B-NP
conjunctiva  	conjunctiva  	 NNS	I-NP
( 	( 	 -LRB-	O
HC 	HC 	 NNP	B-NP
;  	;  	 :	O
n = 9 	n = 9 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
ocular  	ocular  	 JJ	B-NP
infection  	infection  	 NN	I-NP
( 	( 	 -LRB-	O
OI 	OI 	 NNP	B-NP
;  	;  	 :	O
n = 19 	n = 19 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
All  	All  	 DT	O
strains  	strains  	 NNS	O
were  	were  	 VBD	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
different  	different  	 JJ	O
concentrations  	concentrations  	 NNS	B-NP
of  	of  	 IN	I-NP
norspermidine 	norspermidine 	 NN	I-NP
,  	,  	 ,	O
spermidine 	spermidine 	 NN	B-NP
,  	,  	 ,	O
putrescine 	putrescine 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
cadaverine  	cadaverine  	 NNS	B-NP
( 	( 	 -LRB-	O
1 	1 	 CD	O
,  	,  	 ,	O
10 	10 	 CD	O
,  	,  	 ,	O
25 	25 	 CD	O
,  	,  	 ,	O
50  	50  	 CD	O
and  	and  	 CC	O
100 μM 	100 μM 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
biofilm  	biofilm  	 JJ	B-NP
formation  	formation  	 NN	I-NP
was  	was  	 VBD	O
tested  	tested  	 VBN	O
on  	on  	 IN	O
microtiter  	microtiter  	 JJ	B-NP
plate 	plate 	 NN	I-NP
.  	.  	 .	O
Besides 	Besides 	 RB	O
,  	,  	 ,	O
cell-free  	cell-free  	 JJ	B-NP
supernatants  	supernatants  	 NN	I-NP
of  	of  	 IN	I-NP
S. epidermidis  	S. epidermidis  	 CD	I-NP
growth  	growth  	 NN	I-NP
at  	at  	 IN	O
4 h  	4 h  	 NNP	O
and  	and  	 CC	O
40 h  	40 h  	 NNP	O
were  	were  	 VBD	O
analyzed  	analyzed  	 VBN	O
by  	by  	 IN	O
gas  	gas  	 NN	B-NP
chromatography  	chromatography  	 VBZ	I-NP
coupled  	coupled  	 VBN	I-NP
to  	to  	 TO	I-NP
mass  	mass  	 JJ	I-NP
spectrometry  	spectrometry  	 NNS	I-NP
( 	( 	 -LRB-	O
GC-MS 	GC-MS 	 NNP	B-NP
)  	)  	 -RRB-	O
to  	to  	 TO	O
detect  	detect  	 VB	O
norspermidine 	norspermidine 	 NNS	B-NP
.  	.  	 .	O
Results  	Results  	 NNS	O
showed  	showed  	 VBD	O
that  	that  	 DT	O
norspermidine  	norspermidine  	 NN	B-NP
at  	at  	 IN	O
25 μM  	25 μM  	 NNP	O
and  	and  	 CC	O
100 μM  	100 μM  	 NNP	O
prevented  	prevented  	 VBD	O
the  	the  	 DT	O
biofilm  	biofilm  	 JJ	B-NP
formation  	formation  	 NN	I-NP
in  	in  	 IN	O
45.16 	45.16 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
14 	14 	 CD	O
/ 	/ 	 CD	O
31 	31 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
16.13 	16.13 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
5 	5 	 CD	O
/ 	/ 	 CD	O
31 	31 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
;  	;  	 :	O
only  	only  	 RB	O
in  	in  	 IN	O
one  	one  	 CD	O
isolate  	isolate  	 NN	O
from  	from  	 IN	O
OI 	OI 	 NNP	B-NP
,  	,  	 ,	O
norspermidine  	norspermidine  	 NN	B-NP
did  	did  	 VBD	O
not  	not  	 RB	O
have  	have  	 VB	O
effect 	effect 	 NN	O
.  	.  	 .	O
Other  	Other  	 JJ	B-NP
polyamines  	polyamines  	 NN	I-NP
as  	as  	 IN	O
spermidine 	spermidine 	 NN	B-NP
,  	,  	 ,	O
putrescine  	putrescine  	 NN	B-NP
and  	and  	 CC	O
cadaverine  	cadaverine  	 NNS	B-NP
did  	did  	 VBD	O
not  	not  	 RB	O
have  	have  	 VB	O
effect  	effect  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
biofilm  	biofilm  	 JJ	B-NP
formation  	formation  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
strains  	strains  	 NNS	O
tested 	tested 	 VBD	O
.  	.  	 .	O
Norspermidine  	Norspermidine  	 NNP	B-NP
was  	was  	 VBD	O
also  	also  	 RB	O
capable  	capable  	 JJ	O
to  	to  	 TO	O
disassemble  	disassemble  	 VB	O
a  	a  	 DT	O
biofilm  	biofilm  	 NN	B-NP
already  	already  	 RB	O
formed 	formed 	 VBN	O
.  	.  	 .	O
Norspermidine  	Norspermidine  	 NNP	B-NP
was  	was  	 VBD	O
detected  	detected  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
40 h  	40 h  	 JJ	O
cell-free  	cell-free  	 JJ	O
supernatant  	supernatant  	 NN	O
of  	of  	 IN	O
S. epidermidis  	S. epidermidis  	 CD	B-NP
by  	by  	 IN	O
GC-MS 	GC-MS 	 JJ	B-NP
.  	.  	 .	O
Norspermidine  	Norspermidine  	 NNP	B-NP
inhibited  	inhibited  	 VBD	O
the  	the  	 DT	O
biofilm  	biofilm  	 JJ	B-NP
development  	development  	 NN	I-NP
of  	of  	 IN	I-NP
S. epidermidis  	S. epidermidis  	 CD	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
surface  	surface  	 NN	O
of  	of  	 IN	O
contact  	contact  	 NN	B-NP
lens 	lens 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
work 	work 	 NN	O
,  	,  	 ,	O
it  	it  	 PRP	O
was  	was  	 VBD	O
demonstrated  	demonstrated  	 VBN	O
that  	that  	 IN	O
S. epidermidis  	S. epidermidis  	 NNP	B-NP
produces  	produces  	 VBZ	O
and  	and  	 CC	O
releases  	releases  	 NNS	O
norspermidine  	norspermidine  	 VBP	O
causing  	causing  	 VBG	O
an  	an  	 DT	O
inhibitory  	inhibitory  	 JJ	B-NP
effect  	effect  	 NN	I-NP
on  	on  	 IN	O
biofilm  	biofilm  	 JJ	B-NP
formation 	formation 	 NN	I-NP
.  	.  	 .	O
Moreover 	Moreover 	 RB	O
,  	,  	 ,	O
this  	this  	 DT	O
is  	is  	 VBZ	O
the  	the  	 DT	O
first  	first  	 JJ	O
time  	time  	 NN	O
showing  	showing  	 VBG	O
that  	that  	 IN	O
clinical  	clinical  	 JJ	B-NP
S. epidermidis  	S. epidermidis  	 CD	I-NP
strains  	strains  	 NNS	I-NP
have  	have  	 VBP	O
different  	different  	 JJ	O
sensitivity  	sensitivity  	 NN	O
to  	to  	 TO	O
norspermidine 	norspermidine 	 VB	O
,  	,  	 ,	O
which  	which  	 WDT	O
suggest  	suggest  	 VBP	O
that  	that  	 IN	O
the  	the  	 DT	O
composition  	composition  	 NN	O
and  	and  	 CC	O
structure  	structure  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
biofilms  	biofilms  	 NN	B-NP
is  	is  	 VBZ	O
varied 	varied 	 VBN	O
.  	.  	 .	O
We  	We  	 PRP	O
propose  	propose  	 VBP	O
that  	that  	 DT	O
norspermidine  	norspermidine  	 NN	B-NP
could  	could  	 MD	O
potentially  	potentially  	 RB	O
be  	be  	 VB	O
used  	used  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
pre-treating  	pre-treating  	 JJ	B-NP
of  	of  	 IN	O
medical  	medical  	 JJ	O
and  	and  	 CC	O
surgical  	surgical  	 JJ	B-NP
devices  	devices  	 NNS	I-NP
to  	to  	 TO	O
inhibit  	inhibit  	 VB	O
the  	the  	 DT	O
biofilm  	biofilm  	 JJ	B-NP
formation 	formation 	 NN	I-NP
.  	.  	 .	O
